GSK3B and amyotrophic lateral sclerosis: Furthermore, SIRT1 activators are generally associated with the treatment of age- related diseases39 and the Gsk3β inhibitor kenpaullone has also been shown to improve motor neuron survival in an amyotrophic lateral sclerosis (ALS) disease background17.